AI assistant
Sending…
CRISPR Therapeutics AG — Director's Dealing 2016
Oct 27, 2016
30936_dirs_2016-10-26_333ec5f9-2c19-4d60-86c4-49fd1c8f769d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CRISPR Therapeutics AG (CRSP)
CIK: 0001674416
Period of Report: 2016-10-24
Reporting Person: COLES N ANTHONY (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-10-24 | Common Stock | A | 35000 | $14.00 | Acquired | 70000 | Indirect |
| 2016-10-24 | Common Stock | A | 35000 | $14.00 | Acquired | 70000 | Indirect |
More from CRISPR Therapeutics AG
Regulatory Filings
2026
Jun 5
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 21
Proxy Solicitation & Information Statement
2026
Apr 21
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 17